These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7425673)

  • 1. Effects of five anti-inflammatory steroids on DNA synthesis by normal skin fibroblasts in vitro.
    Saarni K; Jalkanen M; Hopsu-Havu VK
    Arch Dermatol Res; 1980; 268(2):217-9. PubMed ID: 7425673
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of five anti-inflammatory steroids on collagen and glycoaminoglycan synthessis in vitro.
    Saarni H; Jalkanen M; Hopsu-Havu VK
    Br J Dermatol; 1980 Aug; 103(2):167-73. PubMed ID: 7426413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucocorticosteroids on primary human skin fibroblasts. II. Effects on total protein and collagen biosynthesis by confluent cell cultures.
    Ponec M; Hasper I; Vianden GD; Bachra BN
    Arch Dermatol Res (1975); 1977 Aug; 259(2):125-34. PubMed ID: 907362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticosteroids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts.
    Ponec M; de Haas C; Bachra BN; Polano MK
    Arch Dermatol Res (1975); 1977 Aug; 259(2):117-23. PubMed ID: 907361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical mometasone furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivo.
    Koivukangas V; Karvonen J; Risteli J; Oikarinen A
    Br J Dermatol; 1995 Jan; 132(1):66-8. PubMed ID: 7756153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
    Priestley GC
    Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for the assessment of skin atrophogenicity of topical corticosteroids.
    Marks R
    Dermatologica; 1976; 152 Suppl 1():117-26. PubMed ID: 133834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
    Ahluwalia A; Flower RJ
    Br J Dermatol; 1993 Jan; 128(1):45-8. PubMed ID: 8427821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
    Rampini E; Rastelli A; Cardo P
    Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
    Kerscher MJ; Korting HC
    Acta Derm Venereol; 1992; 72(3):214-6. PubMed ID: 1357864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
    Young JM; Wagner BM; Fisk RA
    Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acid mucopolysaccharide synthesis by hydrocortisone, hydrocortisone 17-butyrate and betamethasone 17-valerate.
    Saarni H; Hopsu-Havu VK
    Br J Dermatol; 1977 Nov; 97(5):505-7. PubMed ID: 145236
    [No Abstract]   [Full Text] [Related]  

  • 15. Steroid-induced atrophy in an animal and human model.
    Kirby JD; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
    Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
    Lange K; Gysler A; Bader M; Kleuser B; Korting HC; Schäfer-Korting M
    Pharm Res; 1997 Dec; 14(12):1744-9. PubMed ID: 9453063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams.
    Shah VP; Elkins J; Skelly JP
    J Pharm Sci; 1992 Jan; 81(1):104-6. PubMed ID: 1619561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity.
    Marks R; Sawyer M
    Arch Dermatol; 1986 Aug; 122(8):881-3. PubMed ID: 2874773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.